Drug
Dexamethasone Ophthalmic
Dexamethasone Ophthalmic is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_4
3
60%
Ph early_phase_1
1
20%
Ph phase_1
1
20%
Phase Distribution
2
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 1Safety & dosage
1(20.0%)
Phase 4Post-market surveillance
3(60.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(1)
Detailed Status
Completed2
unknown1
Recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
66.7%
Most Advanced
Phase 4
Trials by Phase
Early Phase 11 (20.0%)
Phase 11 (20.0%)
Phase 43 (60.0%)
Trials by Status
unknown120%
completed240%
recruiting120%
terminated120%
Recent Activity
1 active trials
Showing 5 of 5
completedphase_1
Pharmacokinetics and Safety of Dexamethasone Eye Drops in Preterm Infants
NCT05387941
terminatedearly_phase_1
A Human Factors Study to Evaluate a Novel Intracanalicular Insertion Device in Healthy Subjects
NCT04945824
recruitingphase_4
DSAEK/DMEK and Cystoid Macular Edema - the Role for Topical NSAIDs (Nepafenac) (DMEC)
NCT05072262
unknownphase_4
Cataract Surgery and Inflammation - the Role for Preoperative NSAIDs (Pre-CIN)
NCT05331690
completedphase_4
PCME Prevention in Patients With NPDR
NCT04940338
Clinical Trials (5)
Showing 5 of 5 trials
NCT05387941Phase 1
Pharmacokinetics and Safety of Dexamethasone Eye Drops in Preterm Infants
NCT04945824Early Phase 1
A Human Factors Study to Evaluate a Novel Intracanalicular Insertion Device in Healthy Subjects
NCT05072262Phase 4
DSAEK/DMEK and Cystoid Macular Edema - the Role for Topical NSAIDs (Nepafenac) (DMEC)
NCT05331690Phase 4
Cataract Surgery and Inflammation - the Role for Preoperative NSAIDs (Pre-CIN)
NCT04940338Phase 4
PCME Prevention in Patients With NPDR
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5